Cebaracetam (INNTooltip International Nonproprietary Name; developmental code names CGS-25248; ZY-15119) is an experimental drug of the racetam group described as a nootropic which was never marketed.

[4] It is the analogue of RGPU-95 in which the terminal amide group has been replaced with a piperazin-2-one moiety.

[4] The mechanism of action of cebaracetam is undefined or unknown.

[1] It reached phase 2 clinical trials prior to its discontinuation.

This drug article relating to the nervous system is a stub.